Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study: Public attitude toward COVID-19 and its treatments is more “infectious” than disease itself

Public attitude toward COVID-19 and its treatments is more "infectious" than the disease itself, according to a new Northwestern Medicine study using Artificial Intelligence (AI) to analyze tweets about the virus.

2 Mar 2021

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

While the vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are administered, and extensive research is conducted for targeted therapeutics to control the COVID-19 (coronavirus disease 2019), it is equally crucial to develop more novel, broad-spectrum antiviral compounds.

2 Mar 2021

Study shows how SARS-CoV-2 affects cytokines compared to other respiratory viruses

Respiratory viruses such as SARS-CoV-2 (causing COVID-19) can often catalyze an overactive immune response that leads to a life-threatening cycle, known as a cytokine storm.

2 Mar 2021

Study: Repurposed arthritis drug did not improve outcomes of patients with severe COVID-19 pneumonia

In a study published online February 25, 2021 in The New England Journal of Medicine, a repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia.

1 Mar 2021

Cellular maps capture COVID-19 pathogenesis in detail

Researchers in the United States and Finland have used tissues from people who died from coronavirus disease 2019 (COVID-19) to generate detailed cellular maps of the pathogenetic processes that occur within affected organs during severe disease.

1 Mar 2021

Is transposable element expression affected by SARS-CoV-2 infection?

A study by researchers in Israel aims to establish whether TE expression is altered in SARS-CoV-2 infected cells, and explores the implications for host immune response.

1 Mar 2021

Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19

Scientists compared the in vitro efficacy and cytotoxicity profiles of PF-00835231 and remdesivir in two human model systems for SARS-CoV-2 infection.

1 Mar 2021

Early tracheostomy could reduce recovery time in critical COVID-19, say researchers

A new study by researchers at the Northwestern University Feinberg School of Medicine, USA, reports the findings of a study on the safety of tracheostomy of critically ill patients and the feasibility of decannulation in most survivors. The researchers view this as a means to improve care in these patients

1 Mar 2021

FDA issues EUA for third COVID-19 vaccine

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

1 Mar 2021

Time to implement measures preventing future viral zoonoses

Now, researchers at the University of Silesia in Katowice and the Poznan University of Medical Sciences in Poland recommend measures to prevent future zoonotic outbreaks. They emphasized the importance of viral surveillance and research on new viral strains as primary strategies to combat these infections.

28 Feb 2021

Bacteria use slimy strategy to defeat antibiotics that fight cystic fibrosis

University of Montana researchers and their partners have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic fibrosis. The research was published Feb. 23 in the journal Cell Reports.

27 Feb 2021

Continued warming of Atlantic coastal waters may enhance the spread of invasive blue catfish

A new study by researchers at William & Mary's Virginia Institute of Marine Science suggests that continued warming of Atlantic coastal waters may enhance the spread of invasive blue catfish within the Chesapeake Bay and other estuaries along the U.S. East Coast.

27 Feb 2021

Advanced practice registered nurses improve quality of care for nursing home residents

Marilyn Rantz still remembers the day she got the call that her mother, whose health had been declining, had fallen and fractured her shoulder. After rushing to the hospital, her mother told her she didn't understand how she ended up on a helicopter pad after the traumatic incident.

27 Feb 2021

Repurposed drugs show antiviral SARS-CoV-2 E channel blocking activity, finds study

A new study by researchers at The Hebrew University of Jerusalem in Israel reports the discovery of a promising group of E channel inhibitors with significant antiviral activity. This could be developed into new treatment agents for this often-deadly virus.

26 Feb 2021

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Researchers have developed a stable and ultrapotent homotrimeric Pittsburgh inhalable Nanobody 21 (PiN-21) against SARS-CoV-2 infection in Syrian hamsters. They demonstrated the high therapeutic efficacy of this homotrimeric Nb, leveraging both intranasal and aerosol delivery.

26 Feb 2021

Why Astrazeneca and J&J’s vaccines, in use the world over, are still on hold in America

The World Health Organization greenlighted emergency use of AstraZeneca and Oxford's covid-19 vaccine this month, following in the steps of the United Kingdom, the European Union and others, who are already injecting it as quickly as possible into the masses.

26 Feb 2021

Study examines the future psyche of post-COVID-19 traveler

Our deep-rooted survival instinct for disease avoidance could make us less willing to embrace strangers and take foreign travel risks.

26 Feb 2021

FDA allows flexible storage and transportation conditions for Pfizer-Biontech COVID-19 vaccine

Today, the U.S. Food and Drug Administration announced that it is allowing undiluted frozen vials of the Pfizer-BioNTech COVID-19 Vaccine to be transported and stored at conventional temperatures commonly found in pharmaceutical freezers for a period of up to two weeks.

26 Feb 2021

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

The first instance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in Austria was observed in the Ski resort Ischgl in early March 2020. Later, the virus spread across Austria and other countries in Northern Europe.

25 Feb 2021

Microbes could predict fatal outcomes in ventilated COVID-19 patients

The study "Microbial signatures in the lower airways of mechanically ventilated COVID19 patients associated with poor clinical outcome" is available as a preprint on the medRxiv* server, while the article undergoes peer review.

25 Feb 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study: Public attitude toward COVID-19 and its treatments is more “infectious” than disease itself

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

Study shows how SARS-CoV-2 affects cytokines compared to other respiratory viruses

Study: Repurposed arthritis drug did not improve outcomes of patients with severe COVID-19 pneumonia

Cellular maps capture COVID-19 pathogenesis in detail

Is transposable element expression affected by SARS-CoV-2 infection?

Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19

Early tracheostomy could reduce recovery time in critical COVID-19, say researchers

FDA issues EUA for third COVID-19 vaccine

Time to implement measures preventing future viral zoonoses

Bacteria use slimy strategy to defeat antibiotics that fight cystic fibrosis

Continued warming of Atlantic coastal waters may enhance the spread of invasive blue catfish

Advanced practice registered nurses improve quality of care for nursing home residents

Repurposed drugs show antiviral SARS-CoV-2 E channel blocking activity, finds study

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Why Astrazeneca and J&J’s vaccines, in use the world over, are still on hold in America

Study examines the future psyche of post-COVID-19 traveler

FDA allows flexible storage and transportation conditions for Pfizer-Biontech COVID-19 vaccine

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

Microbes could predict fatal outcomes in ventilated COVID-19 patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in